Connection

Kim Payne to Antineoplastic Agents

This is a "connection" page, showing publications Kim Payne has written about Antineoplastic Agents.
Connection Strength

0.207
  1. Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia. Leukemia. 2021 05; 35(5):1267-1278.
    View in: PubMed
    Score: 0.106
  2. Application of vitamin D and vitamin D analogs in acute myelogenous leukemia. Exp Hematol. 2017 06; 50:1-12.
    View in: PubMed
    Score: 0.080
  3. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia. Adv Biol Regul. 2017 08; 65:16-25.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.